Return to search

Human Topoisomerases and DNA Geometry: Putting a Positive Twist on Enzyme Action

HUMAN TOPOISOMERASES AND DNA GEOMETRY: PUTTING A POSITIVE TWIST ON ENZYME ACTION
AMY KATHLEEN MCCLENDON
Topoisomerases play critical roles in maintaining DNA topology during cellular processes such as DNA replication in eukaryotes. Movement of the replication machinery through the double helix induces positive supercoiling ahead of the fork and precatenanes behind it. Because topoisomerase I and II create transient single- and double-stranded DNA breaks, respectively, it has been assumed that topoisomerase I relaxes the positive supercoils while topoisomerase II resolves precatenanes.
In contrast to this proposed segregation of function, models for anticancer drug action place topoisomerase II ahead of replication forks. This discrepancy raises the question of whether eukaryotic type II topoisomerases have normal physiological functions ahead of DNA tracking systems. If so, then positively supercoiled DNA might be the preferred substrate for human topoisomerase II?, the isoform involved in replicative processes. Therefore, the work described in this dissertation compared the activities of human topoisomerases on positively and negatively supercoiled DNA in the absence and presence of anticancer drugs, and explored the mechanisms by which topoisomerase II recognizes DNA supercoil geometry.
First, this work characterized the abilities of human topoisomerase II? and ? to relax positively and negatively supercoiled DNA. Topoisomerase II?, but not ?, displayed characteristics that suggest it has the potential to relieve torsional stress ahead of approaching DNA tracking systems efficiently and safely.
Second, this work examined the effects of positive DNA supercoiling on topoisomerase-mediated DNA cleavage and response to anticancer agents. Results indicate that DNA supercoil geometry has a profound influence on topoisomerase II-mediated DNA scission and that topoisomerase I may be an intrinsically more lethal target for anticancer drugs than either type II enzyme.
Lastly, this work explored the mechanism by which topoisomerase II recognizes DNA supercoil geometry. Results suggest that the enzyme recognizes supercoil geometry in a bimodal fashion that involves elements in the N-terminal or central domain for cleavage and the variable C-terminal domain for relaxation. This ability has implications for the catalytic function of topoisomerase II and may account for some of the differences in the physiological roles played by distinct type II enzymes.

Identiferoai:union.ndltd.org:VANDERBILT/oai:VANDERBILTETD:etd-03302006-090925
Date12 April 2006
CreatorsMcClendon, Amy Kathleen
ContributorsKatherine L. Friedman, Lawrence J. Marnett, David E. Ong, Charles R. Sanders, Neil Osheroff, PhD
PublisherVANDERBILT
Source SetsVanderbilt University Theses
LanguageEnglish
Detected LanguageEnglish
Typetext
Formatapplication/pdf
Sourcehttp://etd.library.vanderbilt.edu/available/etd-03302006-090925/
Rightsunrestricted, I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to Vanderbilt University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.

Page generated in 0.0019 seconds